FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> GlaxoSmithKline | Bayer | Roche | Merck | AstraZeneca | Payments

Vermont docs received more secret payments

Tools

A March 2007 article in the Journal of the American Medical Association told the story of pharma companies paying physicians in Vermont over $2.7 million between July 2002 and June 2004, but the advocacy group that reported the original findings now says the amount is actually much higher.

According to the organization Public Citizen, the payments total nearly $5 million and "strongly suggest" violations of American Medical Association and PhRMA professional guidelines, which restrict said payments to $100 per doctor, per occassion.

In fact, the group found that more than $3.2 million worth of the payments were greater than $100 each, representing nearly 90 percent of the payments to physicians by drug companies. Twenty-one drugmakers were said to have kept the payments under wraps. The companies involved included Abbott Labs, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Merck and Roche. 

- see the full story at Pharmalot 

Related Articles:
Lilly tops VT's doc-marketing list
Psych docs mull ties with drugmakers
Arms twisted, pharma promises disclosure
Docs go cold turkey on industry pay
Arms twisted, pharma promises disclosure
Americans want doc payments disclosed


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about GlaxoSmithKline   Bayer   Roche   Merck   AstraZeneca   Payments   Bristol-Myers Squibb   Abbott Laboratories